Clinical Trials · NCT05557604
Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Regina Elena Cancer Institute
- Enrollment
- 146
- Start date
- Feb 2021
- Locations
- 3 sites, Italy
- Primary endpoint
- 3-yr bNED survival